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Universite´ de Strasbourg/Centre National de la Recherche Scientifique, Institut de Chimie, Strasbourg, FranceABSTRACT To gain further insight into the antimicrobial activities of cationic linear peptides, we investigated the topology of
each of two peptides, PGLa and magainin 2, in oriented phospholipid bilayers in the presence and absence of the other peptide
and as a function of the membrane lipid composition. Whereas proton-decoupled 15N solid-state NMR spectroscopy indicates
that magainin 2 exhibits stable in-plane alignments under all conditions investigated, PGLa adopts a number of different
membrane topologies with considerable variations in tilt angle. Hydrophobic thickness is an important parameter that modulates
the alignment of PGLa. In equimolar mixtures of PGLa and magainin 2, the former adopts transmembrane orientations in dimyr-
istoyl-, but not 1-palmitoyl-2-oleoyl-, phospholipid bilayers, whereas magainin 2 remains associated with the surface in all cases.
These results have important consequences for the mechanistic models explaining synergistic activities of the peptide mixtures
and will be discussed. The ensemble of data suggests that the thinning of the dimyristoyl membranes caused by magainin 2 tips
the topological equilibrium of PGLa toward a membrane-inserted configuration. Therefore, lipid-mediated interactions play
a fundamental role in determining the topology of membrane peptides and proteins and thereby, possibly, in regulating their
activities as well.INTRODUCTIONThe increasing resistance of pathogens against the
commonly used antibiotics is of major concern and requires
urgent action and development of alternative treatments (1).
Antimicrobial compounds are widespread in nature (2–4),
and a promising approach is to search for bacteriocidal
and fungicidal molecules to investigate their mechanism
of action and use them as templates for the creation of
more easy-to-prepare and/or more efficient analogs (5,6).
In this manner, a large variety of host defense peptides
have been discovered that are produced when infections
occur and/or are stored in exposed tissues of animals and
plants, thereby establishing a system that can react in
a fast and efficient manner when infections arise (2–4).
Cecropins and magainins were among the first peptides to
be isolated, from insects and frogs, respectively (2,3). These
cationic linear peptides exhibit a broad spectrum of antimi-
crobial activities, although the spectrum varies with
sequence and the resulting differences in physicochemicalSubmitted September 28, 2010, and accepted for publication January 31,
2011.
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0006-3495/11/03/1473/8 $2.00properties. Several host defense peptides have also been
shown to exhibit virucidal and tumoricidal activities (7,8).
The peptides of the magainin class carry an overall posi-
tive charge, and they exhibit pronounced interactions with
phospholipid membranes, where they adopt amphipathic
a-helical conformations (9–11). By interacting with phos-
pholipid bilayers, the peptides cause membrane pore forma-
tion, a decrease in Ohmic resistance, and a concomitant
collapse of the TM electrochemical gradients by molecular
mechanisms discussed below. Such modification of the
membrane characteristics provides an explanation of the
peptide cell-killing activities, as the formation of pores
affects cellular respiration and deprives sensitive organisms
of their source of energy (for reviews, see, e.g., Bechinger
(5) and Shai (12)).
It is interesting to note that all-D-magainins, all-D-cecro-
pins, cecropins with inverted sequences (retro), or inverse
D-cecropins (retroenantio), all possess the high antibiotic
and pore-forming activities of the parent L-enantiomer,
which is taken as an indication that the cell-killing activities
of these peptides are related to direct interactions with phos-
pholipid membranes rather than through specific, chiral
receptor interactions (13), although more recent evidence
also points to the existence of intracellular targets once
the bacterial or fungal membranes are crossed (for a review,
see Brogden (14)).
When the lipid interactions of magainins and related
cationic antimicrobial peptides were investigated by
biophysical approaches, and in particular oriented solid-
state NMR spectroscopy, the peptides were found to be pref-
erentially aligned parallel to the membrane surface in a widedoi: 10.1016/j.bpj.2011.01.070
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agreement with their amphipathic and highly charged
character (5). IP alignments have also been observed for
a number of magainin analogs (20–22). Based on such
biophysical investigations, in combination with structure-
activity studies (see, e.g., Vogt and Bechinger (23)),
a number of models have been suggested to explain the
pore-forming and antimicrobial properties of these cationic
amphipathic peptides (for details, see Bechinger (5)).
The models include formation of torroidal pores, where
the peptides, together with the lipid, assemble into a supra-
molecular arrangement of high curvature (24,25). An alter-
native proposal is that the peptides accumulate at the
membrane in an alignment parallel to the surface (12).
Once this carpet becomes too dense, the membrane disinte-
grates and openings form. A third possibility is that at lower
peptide concentrations, stochastic fluctuations of the IP
peptides within the membrane surface account for the tran-
sient and stepwise increases in membrane conductivity
observed in experiments (5). Finally, the amphipathic distri-
bution of charges and hydrophobic residues was compared
to the hydrophobic moment of detergents, which, depending
on a number of parameters, such as lipid composition,
peptide concentration, pH, and temperature, can exhibit
a wide variety of different effects on lipid membranes,
ranging from lysis to channel formation, or even an increase
in the stability of lipid bilayers (26). Such models are
confirmed by molecular modeling calculations showing
that magainin 2 causes the formation of membrane lipidic
pores without needing to adopt TM orientations or
peptide-peptide contacts (27).
It has therefore been suggested that, in analogy to deter-
gents, a full description of the peptide-lipid interactions
requires extensive phase diagrams in which the previously
suggested mechanisms, i.e., the carpet, wormhole, and lysis
models, are represented by distinct areas (5,26). It should be
noted that this knowledge has been used to successfully
design short sequences as well as peptide mimetics with
potent antimicrobial properties (28–32).
Even though these charged amphipathic sequences have
been shown to associate with membranes in an IP fashion,
more general models of membrane-associated peptides
consider a series of equilibria where the peptides insert
from the water phase to an interface-associated state,
followed by membrane insertion and oligomerization
(33,34). Such transitions between IP and TM alignments
have been studied by solid-state NMR and oriented circular
dichroism for a number of amphipathic sequences, and the
membrane topology of these sequences has been analyzed
as a function of hydration, peptide/lipid ratio, and lipid
composition (35–37).
Another intriguing observation made with antimicrobial
compounds is the synergistic enhancement of activities in
naturally occurring cocktails of peptide antibiotics observed
for combinations of magainin 2 and PGLa, as well as forBiophysical Journal 100(6) 1473–1480other amphipathic peptides (11,38–41). In particular, when
combinations of equimolar PGLa and magainin 2 in
DMPC or DMPC/DMPG 3:1 (mole/mole) membranes
were studied by 19F or 2H solid-state NMR spectroscopy,
it was observed that PGLa adopts an alignment where the
helix axis is oriented at ~22 relative to the membrane
normal (42,43). These observations have been incorporated
into a scenario where both peptides associate into a TM
helical bundle, but at this time, the alignment of magainin
2 has to our knowledge not been tested experimentally.
Here, using 15N solid-state NMR spectroscopy, we report,
for the first time to our knowledge, the membrane alignment
of magainin 2 in mixtures with PGLa as a function of lipid
composition. The data thereby support models on how these
(and possibly other) polypeptides interact within bilayer
environments, and these models are conceptually different
from previous propositions. To better understand the interac-
tions that influence the bilayer topology of magainin and
PGLa, additional 15N solid-state NMR measurements in
membranes of different lipid composition will be presented.MATERIALS AND METHODS
Materials
The peptides PGLa and magainin 2 were prepared by solid-state synthesis
using a Millipore 9050 automatic peptide synthesizer and Fmoc chemistry.
Unlabeled PGLa was the generous gift of Michael Zasloff. The peptides
(note sequences below) were prepared either unlabeled, where the isotopes
occur in their natural abundance, or selectively labeled at the underlined
positions using commercially available Fmoc-protected amino acid precur-
sors (Euroistopes, Paris, France, or Promochem, Wesel, Germany). All
lipids were from Avanti Polar Lipids (Alabaster, AL). The peptide
sequences are
PGLa, GMASKAGAIA GKIAKVALKA L-NH2
Magainin 2, GIGKFLHSAK KFGKAFVGEI MNS
The underlined amino acid residues indicate where 15N labeled amino
acids (one at a time) have been incorporated. The peptides were purified
by reverse-phase high-performance liquid chromatography, and their iden-
tity and purity were analyzed by analytical high-performance liquid chro-
matography and matrix-assisted laser desorption/ionization mass
spectrometry (>90%).Sample preparation
A homogeneous mixture of lipid and peptide was obtained by codissolving
the membrane components in chloroform/methanol (1:1 by volume). The
solution was spread onto ultra thin coverglasses (8  22 mm, Marienfeld,
Lauda-Ko¨nigshofen, Germany) and dried, first in air and thereafter in
high vacuum overnight. Membranes were equilibrated at 93% relative
humidity, and where it was necessary to obtain hydration in the liquid-disor-
dered state, the membranes were further exposed to higher temperatures
(310 K) and 100% relative humidity for 2 h before the glass slides were
stacked on top of each other.NMR spectroscopy
Proton-decoupled 31P solid-state NMR spectra were acquired at 161.953
MHz on a Bruker (Rheinstetten, Germany) Avance widebore 400 NMR
Lipid-Mediated Peptide Interactions 1475spectrometer equipped with a double-resonance flat-coil probe (44). A
phase-cycled Hahn-echo pulse sequence (45) with a p/2 pulse of 2.5 ms,
a spectral width of 75 kHz, an echo delay of 40 ms, and a recycle delay
of 3 s were used. Spectra were referenced externally to 85% H3PO4 at
0 ppm.
Proton-decoupled 15N cross-polarization (CP) spectra of static aligned
samples were acquired at 40.54 MHz on a Bruker Avance widebore
400-MHz NMR spectrometer equipped with a double-resonance flat-coil
probe (44). An adiabatic CP pulse sequence was used (46) with spectral
width, acquisition time, CP contact time, and recycle delay time of
75 kHz, 3.5 ms, 0.8 ms, and 3 s, respectively. The 1H p/2 pulse and spinal
64 heteronuclear decoupling field strengths were 42 kHz. A total of 40,000
scans were accumulated, and the spectra were zero-filled to 4096 points.
The spectra were recorded at temperatures well above the gel-to-liquid
phase transitions of the lipids (e.g., Tc ¼ 271 K and 296 K for POPC and
DMPC, respectively (for other lipids, cf. Table 2 of Harzer and Bechinger
(47)). Typically, a 200-Hz exponential line-broadening was applied before
Fourier transformation. Spectra were externally referenced to 15NH4Cl at
40.0 ppm. An Oxford temperature control unit was used.FIGURE 1 Proton-decoupled 15N solid-state NMR spectra of peptide
mixtures reconstituted into oriented DMPC/DMPG 3:1 (mole/mole)
membranes at 310 K. Samples were equilibrated at 93% RH in all cases.
(A) [15N-Ala14]-PGLa and unlabeled magainin 2. (B) [15N-Ala14]-PGLa
and [15N-Ala15]-magainin 2. (C) Unlabeled PGLa and [15N-Ala15]-magai-
nin 2. In all cases, the molar ratios of PGLa/magainin 2/DMPC/DMPG
were 1:1:75:25. The bilayer model above the NMR spectra illustrates the
correlation between the 15N chemical shift and the membrane alignment
of helical peptides. The spectrum shown in A is characterized by a predom-
inant TM and a smaller IP signal intensity, indicating that a sensitive equi-
librium is governing the PGLa membrane interactions (cf. text for details).RESULTS AND DISCUSSION
In a first series of experiments, mixtures of PGLa and
magainin were reconstituted into oriented DMPC/DMPG
3:1 (mole/mole) membranes, and the topological state of
each of the cationic peptides was analyzed by circular
dichroism and proton-decoupled 15N solid-state NMR spec-
troscopy. In the presence of phosphatidylcholine small uni-
lamellar vesicles (SUVs), the circular dicihroism spectra of
the peptides, alone or when present in equimolar amounts,
indicate that the peptides retain their predominantly helical
conformation even in a mixture ((39) and the Supporting
Material). Furthermore, although the different curvature of
SUVs may cause subtle conformational alterations when
compared to planar lipid bilayers, the data are in good agree-
ment with the presence of helical secondary structures
throughout major parts of the sequences, as has been previ-
ously observed in a wide variety of membrane environments
(9,10,16). For solid-state NMR spectroscopy, the peptides
were mixed in such a manner that either one only (Fig. 1,
A and C) or both (Fig. 1 B) carried a 15N label within their
helical domain (9,10). Due to the unique properties of the
15N amide chemical-shift tensor, the approximate alignment
of helical peptides can be obtained directly from the 15N
chemical shift measured from such samples (48). Whereas
TM helical alignments are characterized by 15N chemical
shifts in the 200-ppm region, peptides that orient along the
membrane surface exhibit values of <100 ppm.
The proton-decoupled 15N spectrum of [15N-Ala14]-PGLa
in the presence of unlabeled magainin 2 (Fig. 1 A) shows
that it exhibits a predominant 15N signal intensity at
178 ppm, indicating that in the presence of magainin 2,
[15N-Ala14]-PGLa adopts tilt angles that agree with TM
alignments, as observed in previous investigations using
2H and 19F solid-state NMR spectroscopy (42,49). However,
when magainin 2 was labeled with 15N and investigated in
the presence of an equimolar amount of unlabeled PGLa,
the chemical shift at 82 ppm indicates that [15N-Ala15]-mag-ainin 2 remains aligned parallel to the surface in the pres-
ence (Fig. 1 C) or absence of the other peptide (15,16,50).
The data are confirmed by a third sample, where both
peptides are simultaneously labeled with 15N (Fig. 1 B).
In a next step, the effect of lipid composition on the
membrane topology of PGLa and magainin 2 was further
investigated. It should be noted that most of the early
measurements on these cationic antimicrobial peptides
were performed after they had been individually reconsti-
tuted into 1-palmitoyl-2-oleoyl-phospholipid bilayers, and
these investigations always indicated that the peptides align
parallel to the membrane surface (10,15,16,50–52). There-
fore, to test whether the TM alignment of PGLa (Fig. 1, ABiophysical Journal 100(6) 1473–1480
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is also related to the DMPC/DMPG lipid composition,
additional samples were prepared in which mixtures of
PGLa and magainin2 were reconstituted into POPC or
POPC/POPG 3:1 (mole/mole) membranes (Fig. 2). The
15N chemical shifts for [15N-Ala14]-PGLa (Fig. 2, A and
C) and [15N-Ala15]-magainin 2 (Fig. 2, B and D) of 89
and 84 ppm, respectively, indicate that in all four
membranes tested, both peptides adopt IP alignments. It
should be mentioned that differences in the magainin 2
interactions with DMPC and POPC membranes have also
been noted in previous biophysical investigations (24,53).
Thus, in the model bilayers believed to best represent the
1-saturated-2-unsaturated fatty acyl composition and the
hydrophobic thickness of natural membranes, both peptides
consistently exhibit IP orientations in the presence (Fig. 2)
or absence of the interaction partner (10,15,16,50–52).
Most mechanistic studies of the synergy between magai-
nin 2 and PGLa have been performed on lipid membranes of
fatty acyl composition closely related to those used during
the experiments shown in Fig. 2 (39,54,55). The pioneering
biophysical work by Matsuzaki and co-workers shows that
the membrane pores formed by PGLa, magainin 2, or
mixtures of the two peptides follow similar mechanisms,
which are characterized by lipid flip-flop and peptide trans-
location. The kinetics of these two processes parallel that of
pore formation, as evidenced by calcein release from pre-
formed vesicles (39). Those authors suggested that synergyFIGURE 2 Proton-decoupled 15N solid-state NMR spectra of peptide
mixtures reconstituted into oriented POPC/POPG 3:1 (mole/mole) (A and
B) or POPC (C and D) membranes at 310 K. (A and C) [15N-Ala14]-
PGLa and unlabeled magainin 2. (B and D) Unlabeled PGLa and [15N-
Ala15]-magainin 2. The molar ratios of PGLa/magainin 2/POPC/POPG
were 1:1:75:25 and those of PGLa/magainin 2/POPC were 1:1:100.
Samples were equilibrated at 93% RH in all cases.
Biophysical Journal 100(6) 1473–1480arises from the combination of the faster formation of
membrane openings due to the presence of PGLa with
a pore lifetime intermediate to those measured for magainin
or PGLa alone (39). Mutagenesis experiments and the study
of covalently linked dimers suggest that magainin 2 and
PGLa transiently form a heterodimer of parallel helices
(54,55), which, according to this work, reside on the surface
of the membranes when investigated in palmitoyl-oleoyl
phospholipid bilayers (Fig. 2).
Another question arises as to how the TM insertion of
PGLa in dimyristoyl phospholipids can be explained,
when at the same time, the data shown in Figs. 1 and 2 indi-
cate that the peptides in combination do not form a hetero-
meric TM channel structure (42,49). An alternative model
proposes that the peptides influence each other by modu-
lating the membrane properties (cf. Fig. 3 C in Bechinger
(5)), similar to suggestions made to explain the regulation
of biological activity of larger membrane proteins (56). It
should be noted that membrane hydrophobic thickness has
previously been shown to have a pronounced influence on
the membrane topology of other amphipathic peptides,
such as peptaibols or model sequences (47,57–59). There-
fore, we speculated that the well-known membrane-thinning
effect of magainin 2 (60) could have a significant effect also
on PGLa topology.
To test this hypothesis, we investigated the alignment of
[15N-Ala14]-PGLa alone in phosphatidylcholine membranes
of different fatty acyl chain composition. Indeed, when
reconstituted into phosphatidylcholine bilayers, the
[15N-Ala14]-PGLa helix changes from an IP orientation in
di-C20:1-PC bilayers (15N chemical shift 87 ppm) (Fig. 3
A), POPC (Fig. 3 B), POPE/POPG 3:1 (mole/mole), or
POPC/POPG 3:1 (mole/mole) (10,50) to smaller tilt angles
(i.e., deviating from a perfect IP orientation) in the presence
of the thinner DMPC/DMPG 3:1 (mole/mole) (15N chemi-
cal shift (1085 23) ppm (Fig. 3 C)) and di-C12:0-PC bila-
yers (155 ppm, Fig. 3 D). Finally, the 15N chemical shift of
[15N-Ala14]-PGLa in di-C10:0-PC exhibits a broad chemi-
cal shift distribution between 105 and 160 ppm (maximum
at 132 ppm), suggesting that in thin membranes, the tilt
angle of the membrane-spanning peptide increases again,
as has been observed previously for TM model peptides
(47), or when the membrane alignments of alamethicin in
DMPC and POPC are compared to each other (58). Fig. 4
provides a graphical summary of the 15N chemical shifts
measured and the corresponding PGLa topologies, as well
as a definition of the tilt angle, q. In contrast, magainin 2
exhibits an IP alignment even when associated with the
di-C10:0-PC membrane (the 15N chemical shift of position
15 is 85 ppm (Fig. 3 E)), as well as under all conditions
investigated previously (10,15,16,50–52). Note that the
proton-decoupled 31P NMR spectra of all samples are indic-
ative of well-aligned phospholipid bilayers (Fig. 3, G–L).
Thus, the data show that the hydrophobic thickness of the
membrane has a pronounced influence on the PGLa
FIGURE 3 (A–F) Proton-decoupled 15N solid-state NMR spectra of
[15N-Ala14]-PGLa (A–E) or [15N-Ala15]-magainin 2 (F) in aligned
membranes of different lipid compositions. (G–L) Proton-decoupled 31P
solid-state NMR spectra of the samples in A–F. Lipid compositions were
di-C20:1-PC, 295 K (A and G); POPC, 310 K (B and H); DMPC/DMPG
3:1 (mole/mole), 310 K; di-C12:0-PC, 295 K (C–J); PGLa in di-C10:0-
PC, 295 K (E and K) (for comparison, the spectrum obtained from [15N-
Ala10]-PGLa is shown in gray in E); and magainin 2 in di-C10:0-PC, 295
K (F and L). Peptide concentrations were 2 mol % in all cases. Samples
were equilibrated at 93% RH, except in the case of the gray spectrum in
C, which was equilibrated at 100% RH before data acquisition.
Lipid-Mediated Peptide Interactions 1477topology, but not on that of magainin 2, and we suspect that
this difference is due to the larger hydrophobic angle of the
PGLa helix (39) concomitant with the smaller number of
polar residues being transferred from the interface into the
membrane interior upon peptide reorientation. Whereas the
fatty acyl chain length controls the PGLa topology, few or
no orientational effects are observed due to the presence of
negatively charged phospholipids either for this peptide
(42,49) (Fig. 3, B and C) or for the magainin 2 helix (15).
The series of investigations shown in Figs. 2 and 3 are
indicative that in addition to the IP, tilted, and TM align-
ments, which have been described previously (42,49) and
which correspond to 15N chemical shifts for [15N-Ala14]-PGLa of ~85 ppm (Figs. 1 C and 3, A and B; q¼ 81 accord-
ing to Strandberg et al. (49)), 108 ppm (Fig. 3 C, black line;
q ¼ 53), and 180 ppm (Fig. 1 A; q ¼ 22), additional inter-
mediates are observed (Fig. 3, D and E, 155 and 132 ppm,
respectively). Note that next to the spectral maxima can
be seen shoulders ranging into the 155- and 180-ppm
regions (Figs. 3, C–E), suggesting that in the case of the
thinner membranes, the dominant topologies are in ex-
change with other, less tilted alignments. The resulting spec-
tral line broadening degrades the signal/noise ratio of some
of the spectra, although the integrated signal intensity of all
spectra shown agrees well with the number of accumula-
tions. The TM alignment was confirmed by the 15N chemi-
cal shift spectrum of [15N-Ala10]-PGLa in di-C10:0-PC
(Fig. 3 E, gray line), thereby indicating that the structural
and topological preferences extend over the central core
region of the peptide.
It is notable that the less tilted alignment, although also
present by the 180 ppm shoulder in the spectra shown in
Fig. 3, C–E, is most stable in the presence of magainin 2
(Fig. 1, A and B), suggesting that the physical properties
of the membrane in the presence of magainin 2 and/or
the interactions between the peptides stabilize this
topology. Such peptide-peptide interactions could involve
long-range electrostatic interactions and/or more specific
molecular recognition (39,61). Whereas the strong electro-
static repulsion between the cationic peptides seems to
destabilize close molecular interactions, the experimental
evidence seems to favor a well-defined structural arrange-
ment. First, in the presence of magainin 2, the equilibrium
of PGLa alignments shown in Fig. 4 is shifted toward
a configuration exhibiting a 15N chemical shift of ~180
ppm (Fig. 1, A and B, and 4 B), and very similar 15N chem-
ical shifts of PGLa/magainin mixtures are observed when
the 15N solid-state NMR spectra obtained from oriented
di-C10:0-PC (not shown) and DMPC/DMPG bilayers
(Fig. 1) are compared to each other. Furthermore, a recent
structure of a PGLa-magainin 2 heterodimer in the presence
of dodecylphosphocholine micelles exhibits a number of
interresidual contacts and almost perpendicular relative
alignments of the two peptides, although it is not obvious
how to place this structure into an intact lipid bilayer, as
the hydrophobic faces of both helices are exposed to the
outside of the dimer (11).
Assuming a constant rotational pitch angle the 15N chem-
ical-shift range covering 85–180 ppm corresponds to
changes of the helical tilt of ~45, an angular range that
considerably increases when additional movements around
the helix axis occur (47,48). It is of interest that the 15N
chemical shifts indicate that even in its TM state, the peptide
remains significantly tilted regardless of the hydrophobic
thickness of the membrane, and one may speculate that
this topology assures a better positioning of the K5 and
K19 side chains for snorkeling to the membrane surface
(62) and/or for PGLa-PGLa interactions (63).Biophysical Journal 100(6) 1473–1480
FIGURE 4 Models of PGLa and magainin 2
helix alignments in oriented lipid bilayers. The
PGLa helices are sketched as light gray cylinders,
and the magainin 2 helices are viewed along their
long axis and shown as dark gray circles. (A)
Sketch of how PGLa alone adjusts its alignment
to the membrane hydrophobic thickness. Whereas
the peptide orients along the membrane surface
in thick PC membranes, it spans bilayers made of
shorter fatty acyl chains. The approximate 15N
chemical shifts of [15N-Ala14]-PGLa are also indi-
cated, as is the definition of the tilt angle, q,
between the membrane normal and the helix long
axis. (B) Illustration of how membrane thinning
caused by magainin 2 can trigger topological alter-
ations of PGLa in DMPC (but not POPC)
membranes (cf. text for details). Small populations
or transient additional intermediates (as shown in
A) may exist also for PGLa in the presence of mag-
ainin 2 but they have been omitted for clarity.
1478 Salnikov and BechingerIt has been observed that several amphipathic peptides,
including PGLa, can adopt a number of topological states
depending on lipid composition, peptide/lipid ratio, hydra-
tion, temperature, pH, and the presence of additional
membrane components (19,36,64,65), a situation that is
also illustrated in Fig. 4 A. From a thermodynamic perspec-
tive, these transitions have been characterized by equilibria
such as IP5titled15titled25titled35::::5TM15
TM25TM35etc:
The different TM states could represent, for example,
different tilt angles and/or oligomerization states, and the
possibility exists that the IP topology is also to be diversified
into additional substates. When directly comparing the
ensemble of IP and TM states, interaction energies contrib-
uting to the corresponding Gibbs free energy of transition,
DGIP5TM, arise, for example, from changes of hydrophobic
contributions when amino acid side chains move from the
interface to the membrane interior (34,66), contributions
from the peptide-induced packing defects of the phospho-
lipid membrane, hydrophobic mismatch, and peptide-
peptide interactions (36,47).
The hydrophobic-mismatch contribution has been found
to be particularly important in investigations of peptaibols,
such as the 15-residue peptides zervamicin II or ampullo-
sporin A (57,58), similar to the behavior of PGLa observed
here (Fig. 3, A–E). Although the previous studies indicated
that hydrophobic mismatch has a pronounced influence on
peptide topology, it was also found that the peptaibols adopt
TM alignments only within bilayers that are thinner than
one would expect from their hydrophobic length alone.
Therefore, to explain such differences, other interactions
need to be taken into consideration as well.
In the case of PGLa, a TM alignment is observed when
the thickness of the bilayer is reduced to di-C12:0-phospha-
tidylcholine, which in its pure form exhibits a hydrophobicBiophysical Journal 100(6) 1473–1480thickness of 19.5 A˚ (68). This span finds its geometric corre-
spondence in an a-helix encompassing 13 amino acids,
although the number of residues exposed to the hydrophobic
regions of the membrane may be slightly different due to
changes in the secondary structure of the peptide and/or
adaptations of the fatty acyl chain order parameter that
occur under conditions of hydrophobic mismatch (47,69).
In particular, the PGLa sequence A6–L18 is of correspond-
ing dimensions. It encompasses two cationic residues and is
flanked by two additional lysines whose side chains poten-
tially snorkel to the surface (see primary sequences of
the peptides in the Methods section). Indeed, previous
solid-state NMR and molecular modeling investigations
showed that two (but not three) lysines can be accommo-
dated with TM alignments of amphiphilic model peptides,
as long as other interactions provide suitable driving forces
for compensation (64). These considerations offer an expla-
nation for the stable IP alignment of magainin 2, where three
lysines accumulate in the central region of the peptide, when
at the same time PGLa exhibits a more flexible topology.
To further test the effect of hydrophobic mismatch on
the PGLa topology, the hydration level of the sample shown
in Fig. 3 C was increased through equilibration at 100%
rather than 93% RH. Augmentation of the water content
in the bilayer interface has previously been shown to
increase the lateral headgroup spacing and thereby results
in a decrease of the hydrophobic thickness of phosphatidyl-
choline membranes (60). Indeed, the 15N chemical shift
spectrum of [15N-Ala14]-PGLa in DMPC/DMPG 3:1
(mole/mole) at full hydration (Fig. 3 C, gray line) closely
corresponds to that obtained after equilibrating the di-
C12:0-PC sample at 93% RH (Fig. 3 D). In contrast, the
PGLa alignment remains in a stable IP alignment even after
the hydration of the POPC/POPG sample is augmented (not
shown).
Lipid-Mediated Peptide Interactions 1479In conclusion, the data presented indicate that the
membrane hydrophobic thickness is an important parameter
that modulates the PGLa but not the magainin 2 topology. It
has been shown that addition of magainin 2 to DMPC
membranes results in a decrease of the bilayer thickness
by a few A˚ngstroms (60). It is interesting to note that in
equimolar mixtures of PGLa and magainin 2, the former
adopts TM orientations in liquid-disordered dimyristoyl
membranes but not in the thicker palmitoyl-oleoyl phospho-
lipid bilayers (70). The ensemble of data suggests that the
thinning of the dimyristoyl membranes caused by magainin
2 sufficiently tips the topological equilibria of PGLa toward
a membrane inserted configuration (Fig. 4 B). However,
both peptides, alone or in combination, remain surface-
associated in palmitoyl-oleoyl-phospholipid membranes,
suggesting that this IP topology forms the structural basis
for the synergistic enhancements of antimicrobial and
channel-forming activities.SUPPORTING MATERIAL
A figure showing CD spectra of magainin 2, PGLa, and their mixture
is available at http://www.biophysj.org/biophysj/supplemental/S0006-
3495S0006-3495(11)00200-1.
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